Helicobacter pylori (H.pylori) infection
Conditions
Interventions
Empirical Eradication Therapy Group:Dual regimen
Individualized Eradication Therapy Group:Individualized Eradication Therapy Regimens
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who visit our center due to current Hp infection; 2. Have not undergone eradication therapy; 3. Aged 18-75 years; 4. Both male and female, willing to participate and able to cooperate with this study.
Exclusion criteria
Exclusion criteria: 1. Individuals who have previously undergone H. pylori eradication treatment; 2. Use of medications within 4 weeks prior to enrollment that may affect the study results, such as proton pump inhibitors (PPIs), potassium-competitive acid blockers (P-CABs), bismuth agents, antibiotics, etc.; 3. Patients with gastrointestinal malignancies; 4. Patients who have undergone gastrointestinal surgery; 5. Individuals with significant diseases of the heart, lungs, kidneys, liver, blood, nervous system, endocrine system, or mental health; 6. Those allergic to the medications used in this study; 7. Pregnant or breastfeeding women; 8. Individuals with alcohol abuse; 9. Patients with other medical conditions that may increase treatment-related adverse reactions; 10. Individuals unable to cooperate with this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety (incidence of adverse reactions);Compliance; | — |
Countries
China
Contacts
Public ContactZhou Liya
Peking University Third Hospital
Outcome results
None listed